Till the investment thesis changes and mesoblast is no longer able to produce the stem cells that are being used for different indications . stock price becomes irrelevant in the short term.
Cash flow position is good enough to help the company get rem L across the line for gvhd indication and once that happens its share price will follow accordingly. Recently stocks have seen a decline considering the environment is suggesting increase in interest rates steadily. But once the company passes through the FDA hurdle then it will outperform.
Good luck to all.
The Psychology of Trading, page-353
-
- There are more pages in this discussion • 563 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |